Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Search trials by disease or condition

Enter a condition, keyword, or NCT ID

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results matching your filters

Inhaled Dornase Alpha to Reduce Respiratory Failure After Severe TraumaRecruiting
NCT03368092Phase 3Updated Aug 20, 2026
Sponsor: University Hospital, Strasbourg, France
Multiple Trauma · Respiratory Distress Syndrome, Adult
France
5-aza-4'-Thio-2'-Deoxycytidine (Aza-TdC) in People With Advanced Solid TumorsRecruiting
NCT03366116Phase 1Updated Aug 20, 2026
Sponsor: National Cancer Institute (NCI)
Neoplasms · Solid Tumors
United States
MRI Assessment of Knee Kinematics From Extension to Flexion - Exploratory StudyRecruiting
NCT07016906NAUpdated Aug 20, 2026
Sponsor: GCS Ramsay Santé pour l'Enseignement et la Recherche
Healthy Volunteer
France
Mobile Technology to Reduce Teen Substance MisuseRecruiting
NCT05897164NAUpdated Aug 20, 2026
Sponsor: Evidence-Based Practice Institute, Seattle, WA
Substance Use · Substance Abuse · Suicide · Adolescent
United States
MRI-based Focal Intraprostatic Simultaneous Integrated Boost (SIB) Intensification With De-escalated Adaptive-risk SBRT for Patients With Low to Intermediate Risk Prostate CancerRecruiting
NCT07644598Phase 2Updated Aug 20, 2026
Sponsor: Georgetown University
Prostate Cancer · Localized Prostate Carcinoma
United States
Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial - Part 2Recruiting
NCT07227246Phase 3Updated Aug 20, 2026
Sponsor: Joseph Broderick, MD
Intracerebral Hemorrhage
United States, Canada, Germany, Japan, Spain +1 more
Pembrolizumab in Treating Participants With LeukoplakiaRecruiting
NCT03603223Phase 2Updated Aug 20, 2026
Sponsor: Jonsson Comprehensive Cancer Center
Erythroleukoplakia · Leukoplakia · Verrucous Oral Leukoplakia
United States
Harm Reduction ServicesRecruiting
NCT05776316NAUpdated Aug 20, 2026
Sponsor: NYU Langone Health
Drug Use · Substance Abuse · Mental Illness
United States
Short-Stay Aggressive Hydration to Prevent Post-ERCP PancreatitisRecruiting
NCT07776561NAUpdated Aug 20, 2026
Sponsor: Westmead Hospital
Post-ERCP Pancreatitis · Pancreatitis
Australia
A Pilot Study to Correlate 4-18F- Fluoro-1-naphthol 18F-4FN PET/CT Imaging With Chronic Graft Versus Host Disease ManifestationsRecruiting
NCT07325253Phase 2Updated Aug 20, 2026
Sponsor: M.D. Anderson Cancer Center
Pilot Study · PET/CT Imaging · Host Disease Manifestation
United States
A Phase-3-trial of Acalabrutinib, Obinutuzumab & Venetoclax Compared to Obinutuzumab and Venetoclax in Previously Untreated Patients With High Risk CLLRecruiting
NCT05197192Phase 3Updated Aug 20, 2026
Sponsor: German CLL Study Group
Chronic Lymphocytic Leukemia
Germany
Accelerated Neuromodulation Therapy for Negative Symptoms of SchizophreniaRecruiting
NCT07428460NAUpdated Aug 20, 2026
Sponsor: Douglas Mental Health University Institute
Schizophrenia and Predominant Negative Symptoms
Canada
Benefit of Moderate Intensity Exercise in Patients With Clinical Quiescent Inflammatory Bowel DiseaseRecruiting
NCT07775794NAUpdated Aug 20, 2026
Sponsor: Mahidol University
Inflammatory Bowel Disease (IBD)
Thailand
Efficacy and Safety of Zanubrutinib Plus Tislelizumab Treatment With or Without Sonrotoclax for Patients With Richter TransformationRecruiting
NCT04271956Phase 2Updated Aug 20, 2026
Sponsor: German CLL Study Group
Richter Transformation
Austria, Denmark, Germany
Phase II Trial of Single Agent Belzutifan or Pembrolizumab Versus Combination as Neoadjuvant Therapy in Clear Cell Renal Cell Carcinoma (BLAZE)Recruiting
NCT07187778Phase 2Updated Aug 20, 2026
Sponsor: M.D. Anderson Cancer Center
Clear Cell Renal Cell Carcinoma
United States
Outcomes of the Proprioception and Strengthening Exercise Program in Chronic Plantar FasciitisRecruiting
NCT07754214NAUpdated Aug 20, 2026
Sponsor: Karamanoğlu Mehmetbey University
Plantar Fasciitis, Chronic
Turkey (Türkiye)
Evaluation of the Clinical and Psychological Impact of Vitamin D Replacement in Adolescent Females at Risk for Polycystic Ovarian Syndrome (PCOS)Recruiting
NCT04355572NAUpdated Aug 20, 2026
Sponsor: Yale University
Polycystic Ovarian Syndrome in Adolescent Females · Vitamin D Deficiency
United States
Fluoxetine for the Modification of Colorectal Tumor Immune Cells Before Surgery in Patients With Colorectal CancerRecruiting
NCT06225011Phase 1Updated Aug 20, 2026
Sponsor: Jonsson Comprehensive Cancer Center
Colorectal Adenocarcinoma
United States
Natural History Study of Monoclonal B Cell Lymphocytosis (MBL), Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL), Lymphoplasmacytic Lymphoma (LPL)/Waldenstrom Macroglobulinemia (WM), and Splenic Marginal Zone Lymphoma (SMZL)Recruiting
NCT00923507N/AUpdated Aug 20, 2026
Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
Waldenstrom Macroglobulinemia · Lymphoplasmacytic Lymphoma · Monoclonal B-Cell Lymphocytosis · Small Lymphocytic Lymphoma
United States
Safety, Tolerability and Efficacy of Semaglutide Depot in Subjects With Type-2 Diabetes MellitusRecruiting
NCT07563699Phase 1, Phase 2Updated Aug 20, 2026
Sponsor: Mapi Pharma Ltd.
Diabete Type 2
Israel
Effect of a Humanoid Robot With Virtual Reality Games to Train Arm Function in Children With Cerebral Palsy - THRIVE TrialRecruiting
NCT06881407NAUpdated Aug 20, 2026
Sponsor: Georgia State University
Cerebral Palsy (CP)
United States
Quizartinib, Decitabine, and Venetoclax in Treating Participants With Untreated or Relapsed Acute Myeloid Leukemia or High Risk Myelodysplastic SyndromeRecruiting
NCT03661307Phase 1, Phase 2Updated Aug 20, 2026
Sponsor: M.D. Anderson Cancer Center
Acute Myeloid Leukemia · Myelodysplastic Syndrome · Recurrent Acute Myeloid Leukemia · Recurrent Myelodysplastic Syndrome
United States
Personalized Reduction of Chemotherapy Intensity Through ctDNA Evaluation for the Treatment of Patients With Advanced Hodgkin LymphomaRecruiting
NCT06745076Phase 2Updated Aug 20, 2026
Sponsor: University of Washington
Advanced Hodgkin Lymphoma · Classic Hodgkin Lymphoma · Lugano Classification Stage III Hodgkin Lymphoma AJCC v8 · Lugano Classification Stage IV Hodgkin Lymphoma AJCC v8
United States
Ivosidenib and Venetoclax With or Without Azacitidine in Treating Patients With IDH1 Mutated Hematologic MalignanciesRecruiting
NCT03471260Phase 1, Phase 2Updated Aug 20, 2026
Sponsor: M.D. Anderson Cancer Center
Acute Myeloid Leukemia · Hematopoietic and Lymphoid System Neoplasm · Myelodysplastic Syndrome · Myeloproliferative Neoplasm
United States
Personalized Metacognitive Training for Psychosis: A Randomized Controlled TrialRecruiting
NCT07146802NAUpdated Aug 20, 2026
Sponsor: University Hospital, Strasbourg, France
Schizophrenia Spectrum Disorder
France

Previous page Next page